BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 3125834)

  • 1. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis.
    Kline WE
    Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834
    [No Abstract]   [Full Text] [Related]  

  • 2. Current status of posttransfusion hepatitis.
    Alter HJ; Holland PV; Purcell RH
    Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-B post-transfusion hepatitis associated with hepatitis B core antibodies in donor blood.
    Vyas GN; Perkins HA
    N Engl J Med; 1982 Mar; 306(12):749-50. PubMed ID: 6801510
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-B post-transfusion hepatitis with hepatitis B core antibodies in donor blood.
    Katchaki JN; Siem TH; Brouwer R
    N Engl J Med; 1982 Sep; 307(10):628-9. PubMed ID: 6810169
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
    Takano S; Omata M; Ohto M; Satomura Y
    Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
    Sugg U
    Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to the task of reducing the incidence of post transfusion non-A, non-B hepatitis].
    Hernández Sánchez MC; Vila Enriquez P; Alvarez Hernández M
    Sangre (Barc); 1989 Jun; 34(3):248-9. PubMed ID: 2503897
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for the prevention of post-transfusion hepatitis.
    Mintz PD
    Ann Clin Lab Sci; 1984; 14(3):198-207. PubMed ID: 6428295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B, hepatitis.
    Hoyos M; Sarrión JV; Pérez-Castellanos T; Prieto M; Marty ML; Garrigues V; Berenguer J
    Hepatology; 1989 Mar; 9(3):449-51. PubMed ID: 2493415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor notification for positive non-A, non-B hepatitis surrogate testing.
    Brubaker DB; Ukkestad S; Myhre BA
    West J Med; 1987 May; 146(5):620. PubMed ID: 3109126
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-A, non-B hepatitis: a contemporary assessment.
    Blum HE; Vyas GN
    Haematologia (Budap); 1982; 15(2):153-73. PubMed ID: 6819208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
    Katz L; Strong DM; Tegtmeier G; Stramer S
    Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should antibody to hepatitis B core antigen be tested in routine screening of donor corneas for transplant?
    Mattern RM; Cavanagh HD
    Cornea; 1997 Mar; 16(2):138-45. PubMed ID: 9071525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selection of donors in the prevention of post-transfusion viral hepatitis].
    Massaro AL
    Riv Emoter Immunoematol; 1985; 32(2):156-9. PubMed ID: 3937210
    [No Abstract]   [Full Text] [Related]  

  • 18. Posttransfusion hepatitis: a persistent problem.
    Ramirez AM; Woodfield DG
    N Z Med J; 1987 Oct; 100(834):649-51. PubMed ID: 3132660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missed opportunities: ALT and anti-HBc as surrogate tests for hepatitis.
    Bettigole R; Shastri KA
    J Med; 1997; 28(5-6):363-9. PubMed ID: 9604794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transfusion hepatitis C virus infection.
    Kleinman S; Busch M; Holland P
    N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.